We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad. In ...

Robert F. Kennedy Jr., President-elect Donald Trump‘s nominee to lead the Department of Health and Human Services, wants to ...

Biotech has lagged even more. The S&P Biotechnology Select Industry Index has returned about 3 per cent annually over 10 ...

While pediatric atopic dermatitis cases rose globally between 2000 and 2021, the prevalence rate dropped, showing important ...

Cancer treatment is undergoing a revolution, and immunotherapy is leading the charge. Unlike traditional methods like ...

Cancer is now the second leading cause of death worldwide, and rates are climbing-especially in younger adults. Breast, ...

In a report released on January 16, David Risinger from Leerink Partners maintained a Buy rating on AnaptysBio (ANAB – Research Report). The ...

Leerink Partners analyst David Risinger maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report) on January 16. The company’s ...

Diabetic Markers Market. In 2023, the global diabetic markers market is expected to be worth USD 928.1 million. The market is ...